{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T15:27:11Z","timestamp":1781796431721,"version":"3.54.5"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[1999,9,1]],"date-time":"1999-09-01T00:00:00Z","timestamp":936144000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1999,9,1]],"date-time":"1999-09-01T00:00:00Z","timestamp":936144000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[1999,9]]},"DOI":"10.1023\/a:1018955126402","type":"journal-article","created":{"date-parts":[[2003,2,19]],"date-time":"2003-02-19T17:07:13Z","timestamp":1045674433000},"page":"1412-1416","source":"Crossref","is-referenced-by-count":26,"title":["Pharmacokinetic-Pharmacodynamic Modeling of Ipamorelin, a Growth Hormone Releasing Peptide, in Human Volunteers"],"prefix":"10.1007","volume":"16","author":[{"given":"Jogarao V. S.","family":"Gobburu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Agers\u00f8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Jusko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Ynddal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"303679_CR1","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/B978-0-12-571148-7.50011-7","volume":"48","author":"B. M. Lippe","year":"1993","unstructured":"B. M. Lippe and J. M. Nakamoto. Conventional and nonconventional uses of growth hormone. Recent Prog. Horm. Res.\n48:179-235 (1993).","journal-title":"Recent Prog. Horm. Res."},{"key":"303679_CR2","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1507\/endocrj.43.Suppl_S57","volume":"43","author":"K. K. Ho","year":"1996","unstructured":"K. K. Ho, A. J. O'Sullivan, and D. M. Hoffman. Metabolic actions of growth hormone in man. Endocr. J.\n43:S57-63 (1996).","journal-title":"Endocr. J."},{"key":"303679_CR3","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1651-2227.1998.tb01464.x","volume":"87","author":"M. Oyarzabal","year":"1998","unstructured":"M. Oyarzabal, M. Aliaga, M. Chueca, G. Echarte, and A. Ulied. Multicentre survey on compliance with growth hormone therapy: what can be improved? Acta. Paediatr.\n87:387-391 (1998).","journal-title":"Acta. Paediatr."},{"key":"303679_CR4","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/978-3-662-11054-6_25","volume-title":"Advances in Growth Hormone and Growth Factor Research","author":"C. Pintor","year":"1989","unstructured":"C. Pintor, S. Loche, R. Puggioni, S. G. Cella, V. Locatelli, A. Lampis, and E. E. Muller. Growth hormone deficiency states: approach by CNS-acting compounds. In Advances in Growth Hormone and Growth Factor Research, eds. E.E. Muller, D. Cocchi, and V. Locatelli, pp. 375-388, Pythogora press, Springer-Verlag, Berlin-Heidelberg, Germany (1989)."},{"key":"303679_CR5","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1515\/JPEM.1993.6.1.21","volume":"6","author":"C. Y. Bowers","year":"1993","unstructured":"C. Y. Bowers. GH releasing peptides-structure and kinetics. J. Pediatr. Endocrinol.\n6:21-31 (1993).","journal-title":"J. Pediatr. Endocrinol."},{"key":"303679_CR6","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1021\/jm9801962","volume":"41","author":"M. Ankersen","year":"1998","unstructured":"M. Ankersen, N. L. Johansen, K. Madsen, B. S. Hansen, K. Raun, K. K. Nielsen, H. Thogersen, T. K. Hansen, B. Peschke, J. Lau, B. F. Lundt, and P. H. Andersen. A new series of highly potent growth hormone-releasing peptides derived from ipamorelin. J. Med. Chem.\n41:3699-3704 (1998).","journal-title":"J. Med. Chem."},{"key":"303679_CR7","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1210\/edrv.18.5.0316","volume":"5","author":"R. Smith","year":"1997","unstructured":"R. Smith; L. H. T. Van der Ploeg, A. D. Howard, S. D. Feighner, K. Cheng, G. J. Hickey, M. J. Wyvratt, M. H. Fisher, R. P. Nargund, and A. A. Patchett. Peptidomimetic regulation of growth hormone secretion. Endocrinol. Rev.\n5:621-645 (1997).","journal-title":"Endocrinol. Rev."},{"key":"303679_CR8","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1210\/jcem-70-4-975","volume":"70","author":"C. Y. Bowers","year":"1990","unstructured":"C. Y. Bowers, G. A. Reynolds, D. Durham, C. M. Barrera, S. S. Pezzoli, and M. O. Thorner. Growth hormone (GH)-releasing peptide stimulates GH release in normal men and acts synergistically with GH-releasing hormone. J. Clin. Endocrinol. Metab.\n70:975-982 (1990).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"303679_CR9","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1080\/004982598238976","volume":"28","author":"P. B. Johansen","year":"1998","unstructured":"P. B. Johansen, K. T. Hansen, J. V. Andersen, and N. L. Johansen. Pharmacokinetic evaluation of ipamorelin and other peptidyl growth hormone secretagogues with emphasis on nasal absorption. Xenobiotica\n28:1083-1092 (1998).","journal-title":"Xenobiotica"},{"key":"303679_CR10","volume-title":"NONMEM user's guide","year":"1992","unstructured":"S. L. Beal, L. B. Sheiner, editors. NONMEM user's guide. San Francisco, CA: NONMEM Project Group, University of California; 1992."},{"key":"303679_CR11","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/BF01061691","volume":"24","author":"N. L. Dayneka","year":"1993","unstructured":"N. L. Dayneka, V. Garg, and W. J. Jusko. Comparison of four basic models of indirect pharmacodynamic responses, J. Pharmacokin. Biopharm.\n24:457-478 (1993).","journal-title":"J. Pharmacokin. Biopharm."},{"key":"303679_CR12","first-page":"1168","volume":"83","author":"C. Pihoker","year":"1998","unstructured":"C. Pihoker, G. L. Kearns, D. French, and C. Y. Bowers. Pharmacokinetics and pharmacodynamics of growth hormone-releasing peptide-2: A phase I study in children. J. Clin. Endocrinol. Metab.\n83:1168-1172 (1998).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"303679_CR13","first-page":"S","volume":"1","author":"S. S. Hong","year":"1998","unstructured":"S. S. Hong, P. Veng-Pedersen, H. Agersoe, and L. Yndal. Semiparametric pharmacodynamic (PD) modeling of biocompound stimulation drugs. PD of a new human growth hormone releasing peptide (GHR). Pharm. Sci. Suppl.\n1:S-236 (1998).","journal-title":"Pharm. Sci. Suppl."},{"key":"303679_CR14","first-page":"3746","volume":"81","author":"K. Friend","year":"1996","unstructured":"K. Friend, A. Iranmanesh, and J. D. Veldhuis. The orderliness of the growth hormone (GH) release process and the mean mass of GH secreted per burst are highly conserved in individual men on successive days. J. Clin. Endocrinol. Metab.\n81:3746-3753 (1996).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"303679_CR15","doi-asserted-by":"crossref","first-page":"7686","DOI":"10.1073\/pnas.84.21.7686","volume":"84","author":"J. D. Veldhuis","year":"1987","unstructured":"J. D. Veldhuis, M. L. Carlson, and M. L. Johnson. The pituitary gland secretes in bursts: appraising the nature of glandular secretory impulses by simultaneous multiple-parameter deconvolution of plasma hormone concentrations. Proc. Natl. Acad. Sci. USA\n84:7686-7690 (1987).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"303679_CR16","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1210\/jcem-72-6-1312","volume":"72","author":"W. K. DeBell","year":"1991","unstructured":"W. K. DeBell, S. S. Pezzoli, and M. O. Thorner. Growth hormone (GH) secretion during continuous infusion of GH-releasing peptide: partial response attenuation. J. Clin. Endocrinol. Metab.\n72:1312-1316 (1991).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"303679_CR17","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1530\/eje.0.1390552","volume":"139","author":"K. Raun","year":"1998","unstructured":"K. Raun, B. S. Hansen, N. L. Johansen, H. Thogersen, K. Madsen, M. Ankersen, and P. H. Andersen. Ipamorelin, the first selective growth hormone secretagogue. Eur. J. Endocrin.\n139:552-561 (1998).","journal-title":"Eur. J. Endocrin."}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1018955126402.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1018955126402\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1018955126402.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T07:40:41Z","timestamp":1754034041000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1018955126402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,9]]},"references-count":17,"journal-issue":{"issue":"9","published-print":{"date-parts":[[1999,9]]}},"alternative-id":["303679"],"URL":"https:\/\/doi.org\/10.1023\/a:1018955126402","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,9]]}}}